Cargando…

Preferential expression of NY-BR-1 and GATA-3 in male breast cancer

BACKGROUND: Male breast cancer is an uncommon disease often discovered in advanced stage; thus, in the setting of metastatic adenocarcinoma, breast origin must be taken to account. Breast markers as NY-BR-1, GATA-3, mammaglobin, and BRST-2 are established tools for labelling primary and metastatic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biserni, Giovanni Battista, Di Oto, Enrico, Moskovszky, Linda Eszter, Foschini, Maria Pia, Varga, Zsuzsanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794829/ https://www.ncbi.nlm.nih.gov/pubmed/29116378 http://dx.doi.org/10.1007/s00432-017-2542-z

Ejemplares similares

Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015–2018
por: Stevanovic, Lidija, et al.
Publicado: (2019)

Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists
por: Moskovszky, Linda, et al.
Publicado: (2020)

In silico SNP analysis of the breast cancer antigen NY-BR-1
por: Kosaloglu, Zeynep, et al.
Publicado: (2016)

Discrepancies between radiological and histological findings in preoperative core needle (CNB) and vacuum-assisted (VAB) breast biopsies
por: Jörg, Inna, et al.
Publicado: (2020)

Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer
por: Foschini, Maria P., et al.
Publicado: (2020)

Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
por: Balafoutas, Dimitrios, et al.
Publicado: (2013)

Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141(+) dendritic cells to activate naïve and memory NY-ESO-1-specific CD8(+) T cells
por: Masterman, Kelly-Anne, et al.
Publicado: (2020)

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
por: Mir, Muhammad A, et al.
Publicado: (2015)

COVID-19 and the re-opening of schools: a policy maker’s dilemma
por: Fantini, Maria Pia, et al.
Publicado: (2020)

LncRNA GNAS-AS1 facilitates ER(+) breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis
por: Liu, Shi-Qin, et al.
Publicado: (2020)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
por: Li, Yaming, et al.
Publicado: (2019)

NY Cats direct
Publicado: (1986)

Ny CERN-accelerator
Publicado: (1980)

GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy
por: Plum, Patrick Sven, et al.
Publicado: (2020)

Marine sponge‐derived smenospongine preferentially eliminates breast cancer stem‐like cells via p38/AMPKα pathways
por: Tang, Jie, et al.
Publicado: (2018)

Forskare fann ny partikel
por: Dyring, E
Publicado: (1983)

CERN oppdager ny elementarpartikkel
Publicado: (1962)

Breaking the HxNy outbreak
por: Manikandan, Jayapal, et al.
Publicado: (2010)

NY DEC Takes on Fracking
por: Schmidt, Charles W.
Publicado: (2011)

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
por: Das, Krishna, et al.
Publicado: (2019)

Differences in the preferential location and invasiveness of diffuse low‐grade gliomas and their impact on outcome
por: Latini, Francesco, et al.
Publicado: (2020)

Hacia la conquista del cáncer
por: Battista, Orlando Aloysius, 1917-
Publicado: (1962)

Calpain‐2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme
por: Marciel, Michael P., et al.
Publicado: (2017)

Ny partikel bekraftar " Big Bang"
por: Gyllander, R
Publicado: (1983)

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
por: Le Gall, Camille, et al.
Publicado: (2022)

Overexpression of the Aspergillus niger GatA transporter leads to preferential use of D-galacturonic acid over D-xylose
por: Sloothaak, Jasper, et al.
Publicado: (2014)

Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay
por: Meijer, Suzy E, et al.
Publicado: (2021)

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy
por: Campbell, Katie M, et al.
Publicado: (2022)

The predictive value of serum lipids for eye metastases in male nasopharyngeal carcinoma patients
por: Xie, Zhen, et al.
Publicado: (2020)

Ny partikel va jer inte for nagot
por: Browne, M
Publicado: (1977)

Tre miljarder priset for en ny vardsbild
por: Larsen, S
Publicado: (1985)

Ny forsinkelse rammer Big Bang-maskine
Publicado: (2008)

Ny forsinkelse rammer Big Bang-maskine
Publicado: (2008)

The Inebriates' Home, Fort Hamilton, N.Y
Publicado: (1885)

OnTrackNY’s learning healthcare system
por: Humensky, Jennifer L., et al.
Publicado: (2020)

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
por: Cebon, Jonathan S, et al.
Publicado: (2020)

Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)
por: Schröder, Carolien P, et al.
Publicado: (2023)

Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012)

Abstract 93: The Impact of the 2010 NY State Breast Cancer Provider Discussion Law on Type of Breast Reconstruction: An Analysis of 42,137 Patients From the NY SPARCS Database
por: Fu, Rose H., et al.
Publicado: (2018)

Abstract 31: The Impact of the 2010 NY State Breast Cancer Provider Discussion Law on Breast Reconstruction Rates: An Analysis of 42,137 Patients From the NY SPARCS Database
por: Fu, Rose, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fp1h72q8518j7cj5aaoata4t0r